The New (Legal) Marijuana Boom

With the stroke of a pen, President Trump has ushered in a new era of agricultural industry. And it's about time... After almost a century of being banned in the United States without any really good reason, hemp will be legal once again. You are receiving this email because you subscribed to Energy and Capital. [Click here]( to manage your e-mail preferences. [Energy and Capital logo] The New (Legal) Marijuana Boom By Jimmy Mengel Written Jan. 20, 2019 With the stroke of a pen, President Trump has ushered in a new era of agricultural industry. And it's about time... After almost a century of being banned in the United States — without any really good reason — hemp will be legal once again. The 2018 Farm Bill called for the legalization of industrial hemp and has been passed by the Senate and House. Trump just signed off on it at the end of the year... Hemp will be removed from the federal list of controlled substances. That means a plant that has been marginalized, ignored, and downright vilified will now be able to contribute to our country’s economy and take us back to our very agrarian origins. Contrary to popular belief, hemp is NOT marijuana. Hemp and marijuana are both cannabis plants; however, they are different varieties and have very different uses. Hemp doesn't get people high. It is simply a useful plant that could make clothing, food, cosmetics, and — most importantly for my investing purposes — cannabidiol (CBD) that will be used in cannabis-based medicine and beverages. It is that legal distinction and those different qualities that will make investors a nice chunk of change this year... [Marijuana Has Gone Mainstream]( Cannabis is on its way to becoming a $200 billion industry... It’s disrupting beer and tobacco... it’s transforming medicine and agriculture... And that’s why Coca-Cola, Heineken, Molson, and dozens of the world’s largest mainstream companies are buying up all the cannabis stocks they can find. Famous investors like Warren Buffett, Peter Thiel, and Bill Gates are all piling in, too. I’ve done my boots-on-the-ground research... I have a list of five cannabis stocks that are prime targets for these billions... [you could easily make 1,000% or more if you get in now.]( The country was founded on hemp. Both George Washington and Thomas Jefferson grew the plant. Jefferson was particularly fond of it and grew it at his home at Monticello and on his plantation at Poplar Forest. He wrote in 1781 about the plant being “useful for fabrication.” Virginia hemp. Acnida cannabina. ... Tobacco, hemp, flax, and cotton, are staple commodities... Our oldest navy ship, the USS Constitution, required 120,000 pounds of hemp fiber for the lines, rigging, and sails. Hemp was even used as a form of currency for some time in my home state of Maryland. In 1619 Virginia passed a law that required farmers to grow the plant, which could then be used as currency not only in Maryland, but in Virginia and Pennsylvania as well. It was so popular and important that citizens could even pay their taxes with hemp. But then Congress stepped in and ruined the whole party... In 1937 it passed the Marihuana Tax Act, which basically banned hemp production out of fear of its close relative, marijuana. It was Reefer Madness. But today, we’re looking at the hemp plant — and its close relative marijuana — in an entirely new light… President Trump said, “This is an industrial-use product, medicinally as well as other products, and we look forward to developing markets for it if it’s a profitable crop. Agriculture needs new products.” It is a profitable crop. As I mentioned, CBD will be a massive new market that — unlike marijuana — will have the opportunity to flourish without the risk of federal crackdowns. Just look at the sales projections: Now, a $2 billion market sounds great, but the Farm Bill could make that figure skyrocket. This $1 Stock Is Set to Skyrocket The Food and Drug Administration (FDA) recently approved an anti-addiction drug so good that doctors are calling it "a game-changer." Once the big-ticket contracts come in, the share price of the drug's maker will undoubtedly double or even triple. This $1 stock could easily go to $52 a share within the next 12 months. Get in on this now by [clicking here](! Some projections have put CBD ABOVE marijuana in terms of sales. Cannabis analysts at the Brightfield Group have stated that "the hemp-CBD market alone could hit $22 billion by 2022." That is why you need to take a stake in companies that are prime targets for big buyouts... Like I've told you before, giant, name-brand companies like Coca-Cola, Heineken, and Molson are in the process of [pouring billions into cannabis](. Other companies will follow, and smart investors need to place their bets on which companies are the next ones to get bought out. The fact that they can now do so without the fear of federal interference means this process will intensify. With CBD becoming legal, we are going to see CBD beverages, CBD beauty products, CBD medications — even CBD pet food. It will be everywhere, and — right now — you need to buy into companies that are in prime position to ride this trend. [I have a list of companies for you right here...]( The Founding Fathers would be proud. Godspeed, [Jimmy Mengel] Jimmy Mengel [follow basic]( [@mengeled on Twitter]( Jimmy is a managing editor for [Outsider Club]( and the investment director of the personal finance advisory, [The Crow's Nest,](and cannabis stocks advisory, [The Marijuana Manifesto.]( For more on Jimmy, check out his editor's [page](. *Follow Outsider Club on [Facebook]( and [Twitter](. Enjoy reading this article? [Click here]( to like it and receive similar articles to read! Browse Our Archives [Palladium Prices Hit Record: Worth More Than Gold]( [Canadian Cannabis Cash Coming to the U.S.]( [3 Ways to Strike Texas Oil Profits... Without Exxon]( [Raise Cash and Buy Gold]( [Time to Speculate on Gold]( --------------------------------------------------------------- This email was sent to {EMAIL}. It is not our intention to send email to anyone who doesn't want it. If you're not sure why you've received this e-letter, or no longer wish to receive it, you may [unsubscribe here](, and view our privacy policy and information on how to manage your subscription. To ensure that you receive future issues of Energy and Capital, please add newsletter@energyandcapital.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance. [Energy and Capital](, Copyright © 2019, [Angel Publishing LLC](. All rights reserved. 111 Market Place #720 Baltimore, MD 21202. The content of this site may not be redistributed without the express written consent of Angel Publishing. Individual editorials, articles and essays appearing on this site may be republished, but only with full attribution of both the author and Energy and Capital as well as a link to www.energyandcapital.com. Your privacy is important to us -- we will never rent or sell your e-mail or personal information. Please read our [Privacy Policy](. No statement or expression of opinion, or any other matter herein, directly or indirectly, is an offer or the solicitation of an offer to buy or sell the securities or financial instruments mentioned. While we believe the sources of information to be reliable, we in no way represent or guarantee the accuracy of the statements made herein. [Energy and Capital]( does not provide individual investment counseling, act as an investment advisor, or individually advocate the purchase or sale of any security or investment. The publisher, editors and consultants of Angel Publishing may actively trade in the investments discussed in this publication. They may have substantial positions in the securities recommended and may increase or decrease such positions without notice. Neither the publisher nor the editors are registered investment advisors. Subscribers should not view this publication as offering personalized legal or investment counseling. Investments recommended in this publication should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company in question.